These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4375789)

  • 21. [Study of obligate anaerobic bacterial sensitivity to tinidazole and metronidazole (determination of minimal inhibiting concentration--MIC)].
    Kałowski M; Dybicki J; Kedzia A; Lukiański M
    Wiad Lek; 1993 Mar; 46(5-6):211-5. PubMed ID: 8249400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy of tinidazole against anaerobes in comparison with metronidazole, ornidazole, cefoxitin and lamoxactam].
    Werner H; Kuchenbecker K; Hammann R
    Immun Infekt; 1983 Jun; 11(4):143-7. PubMed ID: 6681175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro activity of an ofloxacin-metronidazole combination against anaerobic bacteria. Kinetics of the action of metronidazole against Bacteroides fragilis].
    Dubreuil L; Devos J; Beerens H; Romond C
    Pathol Biol (Paris); 1988 May; 36(5):488-92. PubMed ID: 3043345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of azlocillin, metronidazole and its hydroxy metabolite against anaerobes. Bacteriostatic synergism studies.
    Werner H; Schädler G; Krasemann C
    Arzneimittelforschung; 1983; 33(4):574-7. PubMed ID: 6683537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antibacterial effects of niridazole. II. Effects on aerobic and anaerobic bacteria].
    Hof H; Müller KM
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Nov; 253(2):265-71. PubMed ID: 6299027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative activity of metronidazole and tinidazole against Clostridium difficile and Peptostreptococcus anaerobius.
    Jokipii AM; Jokipii L
    Antimicrob Agents Chemother; 1987 Feb; 31(2):183-6. PubMed ID: 3566248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility testing of anaerobic bacteria.
    Citron D
    Am J Med Technol; 1983 Nov; 49(11):769-72. PubMed ID: 6316785
    [No Abstract]   [Full Text] [Related]  

  • 28. Preparation and biological evaluation of metronidazole derivatives with monoterpenes and eugenol.
    Bkhaitan MM; Alarjah M; Mirza AZ; Abdalla AN; El-Said HM; Faidah HS
    Chem Biol Drug Des; 2018 Dec; 92(6):1954-1962. PubMed ID: 30022596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility testing of anaerobic bacteria.
    Finegold SM; Rolfe RD
    Diagn Microbiol Infect Dis; 1983 Mar; 1(1):33-40. PubMed ID: 6323094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial susceptibility of anaerobic bacteria from the intestinal microflora of healthy children and antimicrobial-treated children in Nicaragua.
    Cáceres M; Carera E; Palmgren AC; Nord CE
    Rev Esp Quimioter; 1998 Sep; 11(3):221-8. PubMed ID: 9795308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time-kill study of the activity of trovafloxacin compared with ciprofloxacin, sparfloxacin, metronidazole, cefoxitin, piperacillin and piperacillin/tazobactam against six anaerobes.
    Spangler SK; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():23-7. PubMed ID: 9222066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation and properties of metronidazole-resistant mutants of Clostridium perfringens.
    Sindar P; Britz ML; Wilkinson RG
    J Med Microbiol; 1982 Nov; 15(4):503-9. PubMed ID: 6294298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of antibiotics on bacterial species composition and metabolic activities in chemostats containing defined populations of human gut microorganisms.
    Newton DF; Macfarlane S; Macfarlane GT
    Antimicrob Agents Chemother; 2013 May; 57(5):2016-25. PubMed ID: 23403424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological significance of the anaerobic metabolism of metronidazole.
    Goldman P; Yeung TC; Koch RL; Beaulieu BB; McLafferty MA
    Prog Clin Biol Res; 1985; 181():127-31. PubMed ID: 2862638
    [No Abstract]   [Full Text] [Related]  

  • 35. Susceptibility of New Zealand isolates to anaerobic bacteria to tinidazole.
    Tannock GW
    N Z Med J; 1979 Aug; 90(642):149-50. PubMed ID: 290923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility of anaerobic bacteria to the new streptogramin RP 59500 in vitro.
    Nord CE; Lindmark A; Persson I
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1064-7. PubMed ID: 2559846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vitro study of the diffusion of metronidazole (Klion) in extracted teeth].
    Ferenczi I; Csukás Z
    Fogorv Sz; 1986 Nov; 79(11):327-31. PubMed ID: 2878831
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antibacterial activities of lincomycin and clindamycin against anerobic bacteria].
    Ninomiya K; Watanabe K; Ueno K; Suzuki S; Mou I
    Jpn J Antibiot; 1973 Apr; 26(2):157-62. PubMed ID: 4354698
    [No Abstract]   [Full Text] [Related]  

  • 39. ["In vitro" microbiological activity of tinidazole compared to 64 anaerobic bacterial strains recently isolated (author's transl)].
    Dainelli B; Magni A; Maragoni F
    Ann Sclavo; 1981; 23(4):421-4. PubMed ID: 7345975
    [No Abstract]   [Full Text] [Related]  

  • 40. Metronidazole-resistant strain of Clostridium perfringens isolated from a clinical specimen.
    Faris B; Faris C; Clark J; Brown R; Poxton IR
    J Infect; 1999 Sep; 39(2):164-5. PubMed ID: 10609539
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.